Posted on 2/1/17
Emulate Adds New Capabilities to "Human Emulation System" for Studying Viral Diseases
Published results demonstrate ability to successfully recreate viral infection of the intestine within Organs-on-Chips technologyEmulate, Inc. announced today that its Organs-on-Chips technology has expanded functionality to . . .
Posted on 2/1/17
Will Berkshire Hathaway Ever Pay A Dividend?
Written on January 30th, 2017, by Nicholas McCullum for Sure Dividend.Berkshire Hathaway (NYSE:BRK.A) is one of the great American success stories.The company’s humble beginnings can be . . .
Posted on 2/1/17
It's Off! Aetna and Humana's Merger Is a Bust
After determining that it's a bad deal for patients, a federal judge has dashed Aetna(NYSE:AET) and Humana's (NYSE:HUM) hopes of merging together to become the nation's . . .
Posted on 2/1/17
PAREXEL Recognized as a 2017 “Training Top 125” by Training Magazine
BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has been recognized among top U.S. businesses in Trainingmagazine’s . . .
Posted on 2/1/17
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage developer of innovative RNA-targeted therapeutics, granted equity awards on January 31, 2017, that were previously approved by the . . .
Posted on 1/31/17
Pulmatrix Announces $5 Million Registered Direct Offering
Pulmatrix, Inc., (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it has entered into a . . .
Posted on 1/31/17
PhysicianOne Urgent Care Continues to Expand in Massachusetts With Newest Location in Medford
The original Urgent Care of Connecticut continues to expand, becoming the Urgent Care in Massachusetts with the opening of its third Massachusetts location, in Medford, this . . .
Posted on 1/31/17
Peak Physical Therapy & Sports Performance Launches Athletic Partnership Program
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide holistic treatment in orthopedic, spine and sports medicine specialties, announces . . .
Posted on 1/30/17
Biogen Inc Makes Up for Lackluster Revenue Growth
Biogen's (NASDAQ:BIIB) fourth-quarter revenue left something to be desired, but the biotech made up for the lackluster growth with a curtailing of expenses, resulting in a . . .
Posted on 1/30/17
Why Did Biogen's Earnings Drop?
Biogen (NASDAQ:BIIB) reported fourth quarter results today, and is up quite a bit despite net income declining on a year on year basis. Let's take a . . .
Posted on 1/28/17
Mayor Jeannette A. McCarthy Welcomes ProEx Physical Therapy to Waltham, MA at Ribbon Cutting Ceremony
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine, celebrated the recent opening of their 16th New England clinic located at . . .
Posted on 1/27/17
5 Things You Need to Know From Bristol-Myers Squibb's Q4 Update
Bristol-Myers Squibb (NYSE:BMY) announced its fourth-quarter and full-year 2016 financial results before the market opened on Thursday. The big drugmaker topped expectations in earlier quarters last . . .
Posted on 1/27/17
Jounce Therapeutics Prices IPO
CAMBRIDGE, Mass., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc., a clinical stage company focused on the discovery and development of novel cancer immunotherapies and . . .
Posted on 1/27/17
Blue Cross Blue Shield of Massachusetts Partners With Ameresco and BlueWave
Blue Cross Blue Shield of Massachusetts (Blue Cross) announced today that it has entered into a long-term agreement to purchase 2.6 megawatts (MW) of net metering . . .
Posted on 1/27/17
Biogen Reports 2016 Revenues of $11.4 Billion
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today reported full year and fourth quarter 2016 financial results, including: Full year total revenues of $11.4 billion, a 6% . . .
Posted on 1/27/17
PAREXEL Expands Managed Access Programs Service Offering
BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an expanded Managed Access Programs service. PAREXEL now offers end-to-end expertise for . . .
Posted on 1/26/17
X4 Pharmaceuticals Announces Initiation of Clinical Study of X4P-001
Clinical program now includes two Phase 1/2 studies in ccRCC to assess X4P-001 in combination with approved therapiesX4 Pharmaceuticals, a clinical stage biotechnology company developing novel . . .
Posted on 1/26/17
Vertex Pharmaceuticals' (VRTX) CEO Jeff Leiden on Q4 2016 Results - Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Q4 2016 Earnings Conference CallJanuary 25, 2017 04:30 PM ETExecutivesMichael Partridge - Vice President of Investor RelationsJeff Leiden - Chairman, Chief Executive OfficerIan . . .
Posted on 1/25/17
DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals
DePuy Synthes Companies today announced an exclusive agreement in the U.S. between DePuy Synthes Sales, Inc. and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) to co-promote EXPAREL®, a . . .
Posted on 1/25/17
Akron Biotechnology Partners in New Manufacturing USA Institute
BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotechnology, LLC (Akron Biotech) is part of a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, . . .
Posted on 1/25/17
AdvanSource Biomaterials and Medibrane Form Strategic Alliance
WILMINGTON, Mass.--(BUSINESS WIRE)--AdvanSource Biomaterials Corporation (OTCQB: ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced a strategic alliance . . .
Posted on 1/25/17
How Risky Is Berkshire Hathaway, Inc.?
Warren Buffett-led Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) has a track record of exceptional performance. In fact, over the past 50 years, Berkshire's stock has risen at an . . .
Posted on 1/25/17
Berkshire Hathaway Sold $2 Billion of Wal-Mart Stock: Time for You to Sell, Too?
WARREN BUFFETT. IMAGE SOURCE: THE MOTLEY FOOL. Warren Buffett's Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) has been unloading its position in Wal-Mart (NYSE:WMT) for more than a year. . . .
Posted on 1/25/17
Better Buy: Biogen Inc. vs. Gilead Sciences Inc.
Investors who bought Biogen (NASDAQ:BIIB) shares five years ago and held on to them would have received a return of more than 130%. Those who bought . . .
Posted on 1/25/17
Aptuit Announces Drug Discovery Collaboration with Massachusetts General Hospital
Aptuit, LLC today announced the start of a collaboration with the Molecular Surgical Laboratory of Massachusetts General Hospital (MGH), directed by Dr. Laurence Rahme, aimed at . . .
Boston
